Radio and PodcastRadio and PodcastLive Radio & Podcasts
HER2-Mutant NSCLC Update: Expanded Approval of Zongertinib artwork
Science & Medicine

HER2-Mutant NSCLC Update: Expanded Approval of Zongertinib

Oncology Data Advisor by Oncology Data Advisor™

Apr 3, 202600:06:23Science & Medicine

Click here to view the full CME/NCPD/CPE/AAPA activity and hear additional insights on the HER2-mutant NSCLC treatment landscape! The FDA’s recent expanded approval of zongertinib marks a significant milestone in the tre...

About This Episode

HER2-Mutant NSCLC Update: Expanded Approval of Zongertinib is an episode from Oncology Data Advisor by Oncology Data Advisor™. Click here to view the full CME/NCPD/CPE/AAPA activity and hear additional insights on the HER2-mutant NSCLC trea...

Podcast

This episode belongs to Oncology Data Advisor.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Apr 3, 2026, 00:06:23 long, audio available.

Related Episodes

Continue listening to more episodes from Oncology Data Advisor.